Netherlands· NL-d567a71e5653
Pyrazinamide CF 500 mg, tabletten
A pyrazinamide product containing pyrazinamide, registered in Netherlands by Centrafarm B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Pyrazinamide is registered in 14 of 19 countries.
Countries holding a registration under ATC J04AK01 (pyrazinamide), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Pyrazinamide · ATC J04AK01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pyrazinamide costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $0.61 in France to $3.20 in Switzerland — a ×5.2 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pyrazinamide · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.20
- FR France$0.61
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- PYRAZINAMIDE
- Manufacturer
- Centrafarm B.V.
- Country
- Netherlands (NL)
- ATC code
- J04AK01
- ATC class
- Pyrazinamide
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id50772
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for pyrazinamide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pyrazinamide · interactions on record
81 records
- 4 severe
- 19 moderate
- 54 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pyrazinamide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPyrazinamide 500mg tabletsMacleods Pharma UK Ltd
- United StatespyrazinamideHikma Pharmaceuticals USA Inc
- FinlandPyrazinamidPharmacal Oy Ab
- CanadaPDP-PYRAZINAMIDEPENDOPHARM DIVISION OF PHARMASCIENCE INC
- NorwayPyrazinamide jenapharmJenapharm GmbH & Co. KG
- PolandPyrazinamid FarmapolPrzedsiębiorstwo Farmaceutyczne Farmapol Sp. z o.o.
- FrancePIRILENE 500 mg, compriméSANOFI WINTHROP INDUSTRIE
- SwitzerlandPyrazinamide Labatec 500 mg, comprimésLabatec Pharma SA
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Pyrafat
- Belgium · Tebrazid
- Bulgaria · Пиразинамид Крка
- Germany · Pyrafat, Pyrazinamid Jenapharm
- Denmark · Pyrazinamid Sad
- Spain · Pirazinamida Prodes
- Finland · Tisamid
- France · Pirilene
- United Kingdom (Northern Ireland) · Pyrazinamide Morningside Healthcare
- Greece · Pyrazinamide Genepharm
- Croatia · Pyrazinamid Krka
- Lithuania · Pyrafat, Pyrazinamide Krka
- Luxembourg · Tebrazid
- Latvia · Pyrazinamide Olpha
- Malta · Pyrazinamide Morningside Healthcare
- Poland · Pyrazinamid Farmapol
- Portugal · Pramide
- Romania · Pirazinamida Atb
- Slovenia · Pirazinamid Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff958f5f-9833-4f12-bcf3-63a62a19717b GET /v1/drugs/ff958f5f-9833-4f12-bcf3-63a62a19717b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h50772_smpc.pdf",
"strength": null,
"atc_label": "Pyrazinamide",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg50772",
"excipients": [
"AARDAPPELZETMEEL",
"CARMELLOSE NATRIUM (E 466)",
"MAGNESIUMSTEARAAT (E 470b)",
"POVIDON K 90 (E 1201)",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)"
],
"substances": [
"PYRAZINAMIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h50772.pdf",
"authorised_at": "1992/09/30",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "50772",
"additional_monitoring": "N"
}See everything about pyrazinamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.